Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aviragen Therapeutics

Aviragen Therapeutics
1984 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
5 FINANCING ROUNDS
3 INVESTMENTS
Description

Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. Geographically all the business activity is functioned through the region of US.

Formerly Known As
Biota Pharmaceuticals, Biota Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 2500 Northwinds Parkway
  • Suite 100
  • Alpharetta, GA 30009
  • United States

Aviragen Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aviragen Therapeutics‘s full profile, request access.

Request full access to PitchBook

Aviragen Therapeutics Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 03-Jun-2015 000000000000000000 000.00 Biotechnology
0000 0000000000000 09-Nov-2012 000000000000000000 Drug Discovery 000 000
Univax Biologics 29-Aug-1995 Merger/Acquisition 00000 Biotechnology 000000 0000
To view this company’s complete investment and acquisition history, request access »

Aviragen Therapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aviragen Therapeutics‘s full profile, request access.

Request full access to PitchBook